KMID : 0359920040230060920
|
|
Korean Journal of Nephrology 2004 Volume.23 No. 6 p.920 ~ p.926
|
|
A Multi-Center Phase 3 Clinical Trial to Assess the Influence to Bleeding and Anticoagulant Effect of Nafamostat Mesilate (Futhan) in Hemodialysis Patients with High Bleeding-Risk
|
|
±èÇöö/Kim HC
Çѽ¿±/±èÇü±Ô/Á¶¿ø¿ë/¼º¼ö¾Æ/¹Ú¼ö±æ/ÀåÀç¿ø/Han SY/Kim HK/Cho WY/Sung SA/Park SK/Chang JW
|
|
Abstract
|
|
|
|
|
KEYWORD
|
|
Hemodialysis, Anticoagulation, Nafamostat mesilate (Futhan), Bleedingrisk
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|